NEW YORK, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA INC, founded in 2007, is a community nonprofit in the Health Care sector that reported $6.2M in total revenue in fiscal year 2024. Revenue surged 43% from the prior year, signaling strong growth momentum.
THE MISSION OF DNDI NORTH AMERICA IS TO CONTRIBUTE TO THE ACHIEVEMENT OF DNDI'S GLOBAL OBJECTIVES, IN PARTICULAR TO STRENGHTEN AND EXPAND DNDI'S SCIENTIFIC, POLICY ADVOCACY, FUNDRAISING, AND COMMUNICATIONS EFFORTS IN NORTH AMERICA BY (A) PROVIDING FOCUSED SUPPORT FOR SPECIFIC R&D PROJECTS AND BUSINESS/PARTNER DEVELOPMENT ACTIVITIES IN NORTH AMERICA;(B) ACHIEVING CONCRETE POLICY CHANGES IN NORTH AMERICA TO CREATE A MORE FAVORABLE ENVIRONMENT FOR NEEDS-DRIVEN R&D FOR NEGLECTED DISEASES;(C) MOBILIZING PUBLIC AND PRIVATE FUNDS IN NORTH AMERICA TO SUPPORT DNDI'S MISSION;(D) INCREASING DNDI'S PROFILE AND VISIBILITY IN NORTH AMERICA, THEREBY DRAWING GREATER PUBLIC ATTENTION TO THE NEED FOR NEGLECTED DISEASE R&D.
GRANTS TO RESEARCH AND DEVELOPMENT FOR NEGLECTED DISEASES: DNDI NORTH AMERICA RAISES FUNDS TO SUPPORT DNDI'S RESEARCH AND DEVELOPMENT (R&D) ACTIVITIES IN ORDER TO CONTRIBUTE TO THE ACHIEVEMENT OF...
GRANTS TO RESEARCH AND DEVELOPMENT FOR NEGLECTED DISEASES: DNDI NORTH AMERICA RAISES FUNDS TO SUPPORT DNDI'S RESEARCH AND DEVELOPMENT (R&D) ACTIVITIES IN ORDER TO CONTRIBUTE TO THE ACHIEVEMENT OF DNDI'S GOAL OF DELIVERING 25 NEW TREATMENTS FOR NEGLECTED PATIENTS BY 2028 AND ESTABLISHING A ROBUST PIPELINE OF NEW POTENTIAL DRUG CANDIDATES. DNDI NOW HAS OVER 30 PROJECTS IN ITS PIPELINE, INCLUDING OVER 20 POTENTIAL NEW CHEMICAL ENTITIES (NCES), AND HAS DELIVERED 12 TREATMENTS OFR SIX DEADLY DISEASES THAT ARE ALREADY IN THE HANDS OF MILLIONS OF PATIENTS.
RAISING PUBLIC AWARENESS AND ADVOCATING FOR NEGLECTED DISEASE R&D:AS PART OF ITS MISSION, DNDI ADVOCATES FOR ENHANCED POLITICAL LEADERSHIP, INCREASED RESOURCES, AND AN ENABLING POLICY ENVIRONMENT TO...
RAISING PUBLIC AWARENESS AND ADVOCATING FOR NEGLECTED DISEASE R&D:AS PART OF ITS MISSION, DNDI ADVOCATES FOR ENHANCED POLITICAL LEADERSHIP, INCREASED RESOURCES, AND AN ENABLING POLICY ENVIRONMENT TO STIMULATE R&D FOR NEGLECTED DISEASES. DNDI NORTH AMERICA ACTIVELY ADVOCATES FOR SOUND POLICIES, PARTICULARLY IN THE UNITED STATES, THAT WILL ENABLE GREATER NEEDS-DRIVEN R&D, INCLUDING APPROPRIATE INCENTIVES AND FINANCING MECHANISMS, INNOVATIVE REGULATORY PATHWAYS THAT EXPEDITE ACCESS, AND OPEN INNOVATION APPROACHES TO INTELLECTUAL PROPERTY MANAGEMENT THAT ENSURE THE WIDEST POSSIBLE SHARING OF RESEARCH KNOWLEDGE AND DATA.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $6,221,917 | $4,350,936 | +0.4% |
| Expenses | $6,349,740 | $4,172,304 | +0.5% |
| Net Income | $-127,823 | $178,632 | -1.7% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| LUIS PIZARRO | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| MEENA AHAMED | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| AFRICA STEWART | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| BENNETT SHAPIRO | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| KRISTINA TORGESON | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| DARIN PORTNOY | CHAIR OF THE BOARD | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| SHING CHANG | SECRETARY | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| JOHN LAWRENCE | TREASURER | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| DELALI ATTIPOE | EXECUTIVE DIRECTOR | 40.00 |
Officer
|
$239,914 | $71,070 | $310,984 |
| RACHEL COHEN | SENIOR ADVISOR, GLOBAL POL | 40.00 |
Officer
|
$213,183 | $68,664 | $281,847 |
| ILAN MOSS | HEAD OF MEDIA AND CONTENT | 40.00 |
Highest
|
$156,476 | $13,940 | $170,416 |
| VISHAL GOYAL | SENIOR CLINICAL PROJECT AN | 40.00 |
Highest
|
$146,409 | $31,015 | $177,424 |
| SHIRLEY LEUNG | SENIOR HR BUSINESS PARTNER | 40.00 |
Highest
|
$106,712 | $44,282 | $150,994 |
| RON SYKES | SENIOR INDIVIDUAL GIVING MANAGER | 40.00 |
Highest
|
$123,284 | $28,363 | $151,647 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $6,221,917 | $6,349,740 | $2,501,704 | $-127,823 |
| 2023 | $4,350,936 | $4,172,304 | $1,819,761 | $178,632 |
| 2022 | $3,931,942 | $3,853,071 | $1,155,455 | $78,871 |
| 2021 | $4,153,290 | $3,993,581 | $1,372,645 | $159,709 |
| 2020 | $3,738,262 | $3,585,571 | $1,506,481 | $152,691 |
| 2019 | $4,627,274 | $4,593,537 | $1,352,194 | $33,737 |
| 2018 | $5,843,041 | $6,026,040 | $2,330,609 | $-182,999 |
Compare DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA INC with other nonprofits in New York and across the country.